EasyJet FirstHalf Losses Widen as Iran Conflict Drives Up Fuel Costs and Weighs on Bookings Trump Delays AI Executive Order Signing Citing Concerns Over Potential Blocker to Progress SP 500 Flat as Consumer Discretionary Strength Offsets Energy and Tech Weakness ARM Growth Drivers Overshadow Antitrust Investigation Risks Indian Stock Exchanges BSE and NSE to Remain Closed on May 28 for Bakri Id Holiday US Banking Sector Posts Profit Increase in First Quarter FDIC Data Shows ABCL Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction Rapid7 Q1 2026 Earnings EPS Surpasses Estimates by 1765 PRTH Q1 2026 Earnings EPS Surges 277 Above Estimates Shares Rally WRBY Q1 2026 Earnings EPS Surpasses Estimates Stock Rises Chart Industries Q1 2026 Earnings Significant EPS Miss Amidst Operational Headwinds QVCGP Q3 2025 Earnings Preferred Stock Reports Significant Loss per Share Amid Retail Headwinds Ring Energy Inc REI Edges Higher Amid Energy Sector Fluctuations International Money Express IMXI Holds Steady Near Support as Remittance Sector Faces Headwinds Flaherty Crumrine Total Return Fund FLC Edges Higher as Price Nears Key Resistance Rocket Companies RKT Edges Higher Approaching Resistance at 1496 Lionheart Holdings Unit CUBWU Holds Steady Near Support Quiet Trading Signals Consolidation Jim Cramer Discusses Analog Devices ADI Market Position Amid Semiconductor Cycle AMX Q1 2026 Earnings EPS Surpasses Estimates Amid Slight Stock Dip Silo Pharma Inc SILO Holds Above 040 Support After Modest Gains Cavco Industries CVCO Q1 2026 Earnings EPS Beat Lifts Modestly as Revenue Detail Remains Sparse Porch Group Q1 2026 Earnings Loss Narrower Than Expected Stock Edges Higher NVST Q1 2026 Earnings EPS Beat of 129 Fails to Lift Stock BankUnited Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed SB Q4 2025 Earnings Slight EPS Miss Amid Dry Bulk Market Volatility CVSA Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction Dogwood Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Preclinical Development